Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Indivior Pharmaceuticals (INDV) Assets Average (2024 - 2025)

Indivior Pharmaceuticals has reported Assets Average over the past 2 years, most recently at $1.3 billion for Q4 2025.

  • Quarterly results put Assets Average at $1.3 billion for Q4 2025, down 15.17% from a year ago — trailing twelve months through Dec 2025 was $1.3 billion (down 15.17% YoY), and the annual figure for FY2025 was $1.3 billion, down 18.12%.
  • Assets Average for Q4 2025 was $1.3 billion at Indivior Pharmaceuticals, down from $1.4 billion in the prior quarter.
  • Over the last five years, Assets Average for INDV hit a ceiling of $2.7 billion in Q3 2024 and a floor of $1.3 billion in Q4 2025.